An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay

Journal of Pharmaceutical and Biomedical Analysis
A M AlakA Chilton

Abstract

An HPLC/MS/MS assay for tacrolimus in whole blood using FR900520 as an internal standard was validated over the standard curve range of 0.100-10.040 ng ml-1. The calibration curve for tacrolimus in human blood gave a slope of 0.2481, an intercept of 0.007, and a correlation coefficient (r) of 0.9996, with no interference noted from human blood, analyte, or internal standard stock solutions. Use of EDTA or heparin as the preservative in blood resulted in no significant differences. Samples were stable for at least the time required to assay the maximum number of samples that could be placed in the automated system. The limit of sensitivity of the assay was set at the concentration of the lowest nonzero standard tested, i.e., 0.100 ng ml-1. However, validation of the assay to a limit of 0.010 ng ml-1 is currently underway. The within-run and between-run precision and accuracy of the method were determined for four quality control samples. The highest CV was seen at 0.1 ng ml-1 (17.6% within-run and 15.9% between-run), with other CV < 5%. The recovery ranged 79.6-81.3% for tacrolimus over the range 0.3-8.0 ng ml-1 and was 63.10 +/- 1.37% for FR900520. There was a linear correlation (r2 = 0.963) between assay results by HPLC/MS/MS ...Continue Reading

References

Apr 27, 2012·Journal of Bacteriology·Dae-Soo KimYoung-Hyo Chang
Nov 20, 2012·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·S M H MehdianT Hammett

❮ Previous
Next ❯

Citations

Apr 29, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·N V S RamakrishnaB Sumatha
Oct 12, 1999·Journal of Clinical Pharmacology·I BekerskyQ Mekki
May 15, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·Michael DetersVolkhard Kaever
Jul 13, 2004·Clinical Pharmacokinetics·Christine E Staatz, Susan E Tett
Oct 3, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sang-Il MinSang Joon Kim
Apr 16, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Rita AllowayNasrullah Undre
Aug 18, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Z WlodarczykN Undre
Feb 1, 2011·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Lutz FischerNasrullah Undre
Dec 2, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yu-Luan ChenMasakazu Kobayashi
Oct 7, 2004·Analytical Biochemistry·Yoshihiro MurakamiEiichi Tamiya
Dec 2, 2008·Drug Development and Industrial Pharmacy·Vivek Baban BorhadeChandrashekhar R Barhate
Jan 22, 2019·Pediatric Transplantation·Nicholas J A WebbUNKNOWN OPTION Study Group
Apr 12, 2019·British Journal of Clinical Pharmacology·Camille RiffJean-Baptiste Woillard
Nov 25, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·U ChristiansG I Kirchner
Nov 6, 2020·Therapeutic Drug Monitoring·Nasrullah UndreIan Dawson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.